News
WHO prequalifies new dengue vaccine
A new vaccine for dengue has received prequalification from the World Health Organization (WHO). TAK-003 is the second dengue vaccine to be prequalified by...
New 3D printing research paves way for personalised medication
A new technique for 3D printing medication has enabled the printing of multiple drugs in a single tablet, paving the way for personalised pills...
Bristol Myers Squibb’s CAR T cell therapy Breyanzi approved by U.S. Food and Drug...
The U.S. Food and Drug Administration (FDA) has granted accelerated approval for Bristol Myers Squibb's Breyanzi ® (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen...
